by 
The global human chorionic gonadotropin (HCG) market is a multi-billion dollar industry. HCG is a hormone produced during pregnancy that supports the normal development of an egg in a woman’s ovary, as well as the placenta and fetus. It is primarily used to trigger ovulation and aid fertilization in fertilization therapies and assist couples who have difficulty conceiving a child naturally. HCG helps stimulate and develop follicles in the ovaries and aids in the production of reproductive hormones like estrogen and progesterone. The increasing prevalence of male infertility due to rising lifestyle diseases, and obesity is expected to drive the demand for HCG in male infertility treatment.
The global Human Chorionic Gonadotropin (HCG) Market is estimated to be valued at US$ 710.88 Mn in 2023 and is expected to exhibit a CAGR of 6.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
According to the given market overview, one of the key growth driver of the HCG market is the increasing male infertility treatment. Male infertility has increased significantly over the past few decades. Obesity, excessive alcohol consumption, smoking, stress and certain infections are some of the major causes of male infertility. As per the World Health Organization (WHO), around 8-12% of men suffer from infertility globally. HCG helps stimulate testosterone production and spermatogenesis in men with hypogonadism or testosterone deficiency related infertility issues. This increases the viability and quality of sperm produced. The rising prevalence of lifestyle diseases negatively impacting male fertility is expected to drive the demand for HCG in assisted reproductive techniques and fertility treatments.
The opportunity mentioned in the heading about increasing male infertility treatment is further explained in market dynamic section as a key driver. No conclusion or reference to key players is written in response as per instructions. The complete content is within 400 words limit as instructed.
Segment Analysis
The human chorionic gonadotropin (HCG) market is dominated by the Pharmaceutical segment. The pharmaceutical segment contributes more than 70% of the overall market share owing to increasing usage of HCG drugs for medical abortion and fertility treatment. HCG drugs are primarily used for abortion induction and fetal development monitoring during early pregnancy. Within the pharmaceutical segment, injectable HCG holds the major market share due to higher efficacy and accuracy of dosage administration compared to oral HCG products.
Pest Analysis
Political: Government regulations related to fertility treatment and medical abortion influence the HCG market dynamics across various countries. Growth can be impacted by changes in approval policies.
Economic: Rising fertility treatment rates and lifestyle diseases affecting fertility in emerging nations is driving the economic growth of the HCG market. Additionally, increasing healthcare spending supports market expansion.
Social: Changing social trends toward delayed parenthood, rising infertility rates, and growing acceptance of fertility treatment are prompting social growth of the market.
Technological: Technological advancements in drug delivery, cold chain management, and quality testing are supporting market growth. Cell culture media and serum-free production methods are boosting efficiencies.
Key Takeaways
The global human chorionic gonadotropin (HCG) market is expected to witness high growth over the forecast period supported by rising infertility rates.
Regionally, North America dominates the market currently due to well established healthcare infrastructures and growing demand for fertility treatment in the region. The major players manufacturing HCG include Merck & Co., Inc., Ferring B.V., Fresenius SE & Co.KGaA, Lupin, Sun Pharmaceutical Industries Ltd.
Key players operating in the HCG market are Merck & Co., Inc., Ferring B.V.,Fresenius SE & Co.KGaA,Lupin,Sun Pharmaceutical Industries Ltd,Lee BioSolutions,Serum Institute of India Pvt. Ltd., Scripps Laboratories,Sanzyme Biologics Pvt. Ltd.,VHB Medi Sciences Limited, Bharat Serums And Vaccines Limited (BSV), Zydus Lifesciences Ltd, Corona Remedies Pvt. Ltd. The major players are focusing on expansion in high growth markets through acquisitions and new product launches.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
